3CPM

DR. MARK NOAR FROM 3CPM LIVE PROCEDURE AT THE NATIONAL MEETING OF GASTROINTESTINAL ENDOSCOPY OF MEXICO

13 September 2019

Dr. Mark Noar will be attending and presenting at the Mexican Association of Gastrointestinal Endoscopy’s Annual Meeting which is taking place in Léon from September 14th  to September 18th 2019. A live procedure using 3CPM®’s electrogastrogram will be performed on the Saturday, in addition to an in-depth lecture about GERD and the importance of the 3CPM®’s EGG in subtyping gastroparesis.

The 3CPM® device detects, records, and analyzes the electrical activity of the stomach to diagnose the gastric myoelectrical activity (GMA) and abnormalities in a quick, accurate, and reproducible manner. These detected abnormalities are associated with several conditions that afflict millions worldwide. This non-invasive, user-friendly system was developed and tested on over 1,000 patients presenting with difficult symptomatology.

3CPM®’s Electrogastrogram is indicated for the following clinical categories: Gastroparesis Tachygastria, Bradygastria, and reflux-related GERD+ Dyspepsia, which affects millions.

If you want to learn more about the technology, please contact us.

WE ARE PROUD TO WELCOME 3CPM!

3 September 2019

We are thrilled to announce that we now represent 3CPM®’s Electrogastrogram (EGG). 3CPM is an innovative organisation that was formed in January 1998 to promote and further the proprietary Electrogastrogram (EGG) technology developed by one of its founders, Kenneth Koch, MD. As a world-renowned expert in diagnostic gastroenterology, Dr. Koch developed the initial EGG and associated EGGSAS software for clinical use.

The 3CPM® device detects, records, and analyzes the electrical activity of the stomach to diagnose the gastric myoelectrical activity (GMA) and abnormalities in a quick, accurate, and reproducible manner. These detected abnormalities are associated with several conditions that afflict millions worldwide. This non-invasive, user-friendly system was developed and tested on over 1,000 patients presenting with difficult symptomatology.

3CPM®’s Electrogastrogram (EGG) is indicated for the following clinical categories: Gastroparesis Tachygastria, Bradygastria, and reflux-related GERD+ Dyspepsia, which affects millions.

To get more information regarding this innovative technology contact us

3CPM ABSTRACT PRESENTATION AT IFSO WORLD CONGRESS

The abstract “Electrogastrography identifies subsets of obese patients undergoing bariatric endoscopic procedures” submitted by Carmen Bautista Altamirano will be presented during the 24th IFSO World Congress in Madrid this September 5th. The presentation will be held in the IFEMA P.M. Varsovia at 16:00.

This abstract is about the 3CPM®’s Electrogastrogram (EGG) which detects, records, and analyzes the electrical activity of the stomach to diagnose the gastric myoelectrical activity (GMA) and abnormalities in a quick, accurate, and reproducible manner. These detected abnormalities are associated with several conditions that afflict millions worldwide. This non-invasive, user-friendly system was developed and tested on over 1,000 patients presenting with difficult symptomatology.

3CPM®’s Electrogastrogram (EGG) is indicated for the following clinical categories: Gastroparesis Tachygastria, Bradygastria, and reflux-related GERD+ Dyspepsia, which affects millions.

To get more information regarding this innovative technology contact us.

It is a pleasure to announce that, for a 5th consecutive year, LOK Corporation will be exhibiting at Medica this November. Come visit our booth to discover many medical innovations and discuss potential business partnership.